Zdrowie i gospodarka · 08/08/2024
FDA Reopens Comment Period for Over-the-Counter Monograph M013
The US Food and Drug Administration is reopening the public comment period for a proposed rule to amend the regulation of over-the-counter pain relievers and anti-inflammatory medications, due to technical issues with the FDA's online portal, and is now accepting comments through the Federal eRulemaking portal.